Prescriber Monitoring for Benign Prostatic Hyperplasia Within a Family Medicine Clinic
- 3 January 2012
- journal article
- research article
- Published by SAGE Publications in Journal of Pharmacy Practice
- Vol. 25 (2) , 164-168
Abstract
Purpose: The purpose of this study was to compare prescriber monitoring for safety and efficacy of medication classes used to treat benign prostatic hyperplasia (BPH). Methods: This was a retrospective chart review of patients diagnosed with BPH who were prescribed medications within a family medicine clinic between January 2008 and August 2010. Patients were divided into those receiving nonselective and uroselective alpha-blockers, 5-alpha reductase inhibitors (5-ARIs), and combination therapy. A chart review was performed with regard to predetermined criteria to monitor how efficacy and adverse effects were assessed by providers in the clinic. Results: A general genitourinary assessment was documented most frequently for patients receiving 5-ARIs and least frequently in patients receiving nonselective alpha-blockers. A digital rectal examination was documented in 11% of patients. Prostate-specific antigen concentrations were assessed evenly across all medication classes and documented in 47% of eligible patients. However, the American Urological Association Symptom Index and quality-of-life questions were not performed on any patients, and assessments of adverse effects were not documented. Conclusion: Although prescribers in a family medicine clinic recorded a general genitourinary assessment for patients receiving BPH medications, a more standardized approach is needed.Keywords
This publication has 11 references indexed in Scilit:
- Effectiveness of a Hypertension Care Management Program Provided by Clinical Pharmacists for VeteransPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2011
- Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patientsAmerican Journal of Health-System Pharmacy, 2010
- Pharmacist Care of Patients With Heart FailureA Systematic Review of Randomized TrialsArchives of internal medicine (1960), 2008
- Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care settingInternational Journal Of Clinical Practice, 2007
- A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care settingInternational Journal Of Clinical Practice, 2007
- Pharmacist Involvement in Primary Care Improves Hypertensive Patient Clinical OutcomesAnnals of Pharmacotherapy, 2004
- The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic HyperplasiaNew England Journal of Medicine, 2003
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Relationship of Antihypertensive Treatment Regimens and Change in Blood Pressure to Risk for Heart Failure in Hypertensive Patients Randomly Assigned to Doxazosin or Chlorthalidone: Further Analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack TrialAnnals of Internal Medicine, 2002
- The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1998